As with the many other “most-favored-nation” deals between the White House and large pharmas, the agreement is short on ...

The Trump administration has finalized a deal with drugmaker AbbVie to cut the cost of certain medicines, marking the latest ...

AbbVie strikes a Trump drug-pricing pact and a $5.6B cancer licensing deal, cutting U.S. prices while expanding its oncology ...

AbbVie is now one of 16 big pharma companies to sign MFN deals with the Trump administration and commit to the expansion of ...

AbbVie has also pledged to participate in TrumpRx and offer many of its products, including Humira, on a direct-to-patient ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The ...

AbbVie on Tuesday announced a voluntary agreement with the Trump administration aimed at expanding access to medicines and lowering costs for US patients while preserving domestic pharmaceutical ...

Though far from the first large drugmaker to strike a pricing deal with the Trump administration, AbbVie’s new accord is ...

A veteran FDA regulator who left last month said the firewall between agency political appointees and drug reviewers “has ...

Global life sciences leader AbbVie says it has entered into a voluntary agreement with the Trump administration to further ...

Jan 12 (Reuters) - AbbVie said on ‌Monday ​that it has ‌struck a three-year deal with U.S. ​President Donald Trump's ...